Allworth Financial’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-500
Closed 1059
2018
Q1
$0 Hold
500
﹤0.01% 913
2017
Q4
$1K Hold
500
﹤0.01% 722
2017
Q3
$1K Hold
500
﹤0.01% 733
2017
Q2
$1K Hold
500
﹤0.01% 727
2017
Q1
$2K Hold
500
﹤0.01% 681
2016
Q4
$1K Hold
500
﹤0.01% 665
2016
Q3
$2K Buy
+500
New +$1.89K ﹤0.01% 622

Other funds holding OREX

Allworth Financial's OREX Position: Q2 2018 in Review

Allworth Financial sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2018, closing a stake of 500 shares.

Allworth Financial first reported a position in OREX in Q3 2016 and held it in 7 quarters. The position peaked at $2K in Q1 2017. 4 funds tracked by Wall St. Rank hold OREX as of Q2 2018.

  • Allworth Financial reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • Allworth Financial sold 500 Orexigen Therapeutics, Inc. shares in Q2 2018.
  • Allworth Financial first reported a position in Orexigen Therapeutics, Inc. in Q3 2016 and held it in 7 quarters.
  • Allworth Financial's Orexigen Therapeutics, Inc. position peaked at $2K in Q1 2017.
  • 4 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2018.

Based on Allworth Financial's 13F filing for Q2 2018, filed 8 Aug 2018.